PMI PE Ratio & Valuation, Is PMI Overvalued

Historical Valuation

Picard Medical Inc (PMI) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Picard Medical Inc (PMI) is between -- to -- according to relative valuation method.

Relative Value

Fair Zone

-----

Current Price：1.14

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Picard Medical Inc (PMI) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Picard Medical Inc (PMI) has a current Price-to-Book (P/B) ratio of 16.83. Compared to its 3-year average P/B ratio of 31.36, the current P/B ratio is approximately -46.32% higher. Relative to its 5-year average P/B ratio of 31.36, the current P/B ratio is about -46.32% higher. Picard Medical Inc (PMI) has a Forward Free Cash Flow (FCF) yield of approximately -10.77%. Compared to its 3-year average FCF yield of -5.24%, the current FCF yield is approximately 105.66% lower. Relative to its 5-year average FCF yield of -5.24%, the current FCF yield is about 105.66% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for PMI competitors is 38.06, providing a benchmark for relative valuation. Picard Medical Inc Corp (PMI.A) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of 34.73%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of PMI increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of PMI in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is PMI currently overvalued or undervalued?

What is Picard Medical Inc (PMI) fair value?

PMI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Picard Medical Inc (PMI) is between to according to relative valuation method.

How does PMI's valuation metrics compare to the industry average?

The average P/S ratio for PMI's competitors is 38.06, providing a benchmark for relative valuation. Picard Medical Inc Corp (PMI) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of 34.73%, this premium appears sustainable.

What is the current P/B ratio for Picard Medical Inc (PMI) as of Mar 05 2026?

As of Mar 05 2026, Picard Medical Inc (PMI) has a P/B ratio of 16.83. This indicates that the market values PMI at 16.83 times its book value.

What is the current FCF Yield for Picard Medical Inc (PMI) as of Mar 05 2026?

As of Mar 05 2026, Picard Medical Inc (PMI) has a FCF Yield of -10.77%. This means that for every dollar of Picard Medical Inc's market capitalization, the company generates -10.77 cents in free cash flow.

What is the current Forward P/E ratio for Picard Medical Inc (PMI) as of Mar 05 2026?

As of Mar 05 2026, Picard Medical Inc (PMI) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Picard Medical Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Picard Medical Inc (PMI) as of Mar 05 2026?

As of Mar 05 2026, Picard Medical Inc (PMI) has a Forward P/S ratio of 0.00. This means the market is valuing PMI at $0.00 for every dollar of expected revenue over the next 12 months.

PMI Valuation